| | | | | |
ANIK Anika Therapeutics Inc | $21,2800 | -1,34% | $294,82M | $80,20K | |
BACC Blue Acquisition Corp. Class A Ordinary Shares | $10,4600 | -0,19% | $294,73M | $1,42K | |
GPAC General Purpose Acquisition Corp. Class A Ordinary Shares | $10,0400 | +0,00% | $294,68M | $5,02K | |
BPRN Princeton Bancorp, Inc. Common Stock (PA) | $42,2200 | -2,18% | $294,53M | $27,55K | |
| $43,6400 | -3,34% | $294,35M | $18,99K | |
ACGC ACP Holdings Acquisition Corp. Class A Ordinary Shares | $9,9900 | -0,10% | $294,35M | $7,01K | |
HCAC Hall Chadwick Acquisition Corp Class A Ordinary Shares | $10,0800 | +0,00% | $294,33M | $166,50K | |
SLN Silence Therapeutics Plc American Depository Share | $13,6000 | -3,55% | $294,27M | $973,75K | |
MTNE CH4 Natural Solutions Corporation | $9,8900 | +0,19% | $293,88M | $3,40K | |
RXST RxSight, Inc. Common Stock | $6,1600 | -3,30% | $293,64M | $619,25K | |
NHIC NewHold Investment Corp III Class A Ordinary shares | $10,6300 | -0,19% | $293,52M | $64,99K | |
IRHO Iron Horse Acquisitions II Corp. Common Stock | $10,0250 | +0,20% | $293,49M | $279,81K | |
CNXU Conexeu Sciences Inc. Common Stock | $8,9050 | -10,90% | $293,27M | $395,78K | |
| $10,3467 | +3,57% | $292,98M | $1,25M | |
JCE Nuveen Core Equity Alpha Fund | $16,9650 | -0,67% | $292,78M | $54,67K | |
